Jet Lag Therapy and consumption by Regional data, Investigation and Growth, Demand by Regions, Research Forecasts To 2030

 

The growth of the market is attributed to the increase in the number of travelers traveling to different time zones and new product launches associated with insomnia                                                  

The global Jet Lag Therapy Market will be worth USD 548.5 million by 2027, according to a current analysis by Emergen Research. Jet lag symptoms cause a wide variety of considerable health hazards to athletes, business executives and seasonal travelers, affecting a wide range of people which is around 1 billion annually. The incidence rate of jet-lag across the globe continues to be unknown, however it impacts a high proportion of around 31 million travelers who depart from the U.S. on a yearly basis for destinations that cross 5 or more number of zones. The effects of jetlag span over a 100 million people annually across the globe. The primary factors which are attributing to the growth of the jetlag therapy market are: growing elderly population, and rising incidence and prevalence rate of circadian rhythm related issues like tiredness, sleep disorders and winter blues. Moreover, high rate of awareness concerning advanced light therapy and treatment with minimum side-effects is anticipated to drive the growth of medical devices product like wearable light-weight medical care devices.

 

Market Size – USD 392.0 Million in 2019, Market Growth - CAGR of 4.3%, Market Trends –Changes in the working shift timings associated with relocation after travel.

 

To get a sample copy of the Jet Lag Therapy Market report, visit @ https://www.emergenresearch.com/request-sample/1019

The global Jet Lag Therapy market is highly consolidated due to the presence of a large number of companies across this industry. These companies are known to make hefty investments in research and development projects. Also, they control a considerable portion of the overall market share, thus limiting the entry of new players into the sector.  The global Jet Lag Therapy market report studies the prudent tactics undertaken by the leading market players, such as partnerships and collaborations, mergers & acquisitions, new product launches, and joint ventures.

 

·         Global Europe Medical Cannabis market competition by TOP MANUFACTURERS, with production, price, and revenue (value) and market share for each manufacturer; the top players including:

Key participants include Ayo (Novalogy), Lumie, Lucimed S.A., The Litebook Company Ltd., Northern Light Technologies, Nature Bright, Re-Time Pty Ltd., and Chrono Eyewear BV. among others.

 

Emergen Research has segmented the Jet Lag Therapy market on the basis of product type, application, and route of administration, distribution channel, and region:

Product Outlook (Revenue, USD Billion; 2017-2027)

·         Prescription Drugs

·         Melatonin

·         Herbal and Natural Products

·         Medical Devices

·         Others

Distribution Channel Outlook (Revenue, USD Billion; 2017-2027)

·         Over the Counter

·         Online

End User Outlook (Revenue, USD Billion; 2017-2027)

·         Business Travelers

·         Cabin Crew

·         Athletes

·         Seasonal Travelers

·         Others

Regional Outlook (Revenue: USD Billion; 2017-2027)

·         North America

1.      U.S.

2.      Canada

3.      Mexico

·         Europe

1.      UK

2.      Germany

3.      France

4.      BENELUX

5.      Rest of Europe

·         Asia Pacific

1.      China

2.      Japan

3.      South Korea

4.      Rest of APAC

·         Latin America

1.      Brazil

2.      Rest of LATAM

·         MEA

1.      Saudi Arabia

2.      UAE

3.      Rest of MEA

 

 

To learn more details about the Jet Lag Therapy Market report, visit @ https://www.emergenresearch.com/industry-report/martech-market

 

Key point summary of the report:

·         n July 2019, Vanda Pharmaceuticals received the FDA approval as a part of its ongoing review of Vanda's supplemental New Drug Application (sNDA) for HETLIOZ® (tasimelteon). The drug was developed in order to treat Jet Lag Disorder especially for eastward trans-meridian travelers.

·         The cabin crew segment is poised to grow considerably at a CAGR of 4.3% throughout the forecasted period. The latest commercial aircrafts cross time zones at nearly the same rate as the earth rotates, and it is the result of these trans-meridian transitions that ultimately leads to the rapid time zone change syndrome also known as jet lag. Jet lag may often lead to short-term memory and poor decision-making; thereby affecting the overall functioning of the cabin crew, if neglected constantly.

·         To cater to the problem, major airlines throughout the globe are trying to find viable solutions for jet lag, by exploring new forms of solutions for managing the passengers’ as well as their employees’ alertness levels.

 

To get a discount on the Medical Cannabis Market Market report, visit @ https://www.emergenresearch.com/request-discount/1019

 

Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.